Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
BMC Medicine|August 14, 2023
Potential value of ctDNA monitoring in metastatic HR + /HER2 - breast cancer: longitudinal ctDNA analysis in the phase Ib MONALEESASIA trialJoanne Chiu, Fei Su, Mukta Joshi, et al.Science Translational Medicine|March 29, 2023
Clonal hematopoiesis detection in patients with cancer using cell-free DNA sequencingLauren Fairchild, Jeanne Whalen, Katie D'Aco, et al.Genome Research|June 12, 2015
The landscape of antisense gene expression in human cancersO Alejandro Balbin, Rohit Malik, Saravana M Dhanasekaran, et al.Nature Communications|October 19, 2013
Reconstructing targetable pathways in lung cancer by integrating diverse omics dataO Alejandro Balbin, John R Prensner, Anirban Sahu, et al.Journal of Neuro-Oncology|November 29, 2019
A Phase Ib/II, open-label, multicenter study of INC280 (capmatinib) alone and in combination with buparlisib (BKM120) in adult patients with recurrent glioblastomaMartin van den Bent, Analia Azaro, Filip De Vos, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 22, 2019
Ceritinib plus Nivolumab in Patients with Advanced ALK-Rearranged Non-Small Cell Lung Cancer: Results of an Open-Label, Multicenter, Phase 1B StudyEnriqueta Felip, Filippo G de Braud, Michela Maur, et al.Oncotarget|February 11, 2016
Non-coding RNA LINC00857 is predictive of poor patient survival and promotes tumor progression via cell cycle regulation in lung cancerLihui Wang, Yanli He, Weijun Liu, et al.Nature Biotechnology|August 2, 2011
Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1, an unannotated lincRNA implicated in disease progressionJohn R Prensner, Matthew K Iyer, O Alejandro Balbin, et al.Nature Communications|December 23, 2014
Transcriptome meta-analysis of lung cancer reveals recurrent aberrations in NRG1 and Hippo pathway genesSaravana M Dhanasekaran, O Alejandro Balbin, Guoan Chen, et al.Science Translational Medicine|December 3, 2011
Personalized oncology through integrative high-throughput sequencing: a pilot studySameek Roychowdhury, Matthew K Iyer, Dan R Robinson, et al.Pageof 2